STAR - Strides Pharma Science

Strides Pharma Science

STAR · Pharma > Pharmaceuticals & Drugs · Chairman: Arun Kumar · MD: R Ananthanarayanan · Listing date: Feb. 2, 2000 · Employees: 2390 · Bangalore · http://www.strides.com

Stock Price vs Company Growth

1.4%

2.2%

3.8%

4.0%

4.5%

36.9%

0.3%

10y

1.3%

all

10.4%

🤔 How to analyze this graph?

Last Traded Price

₹ 844 1.4%

770

1,010

Company Overview

Sales

4,726 Cr

Growth: 8.3%

Profit after Tax

511 Cr

Growth: 28.7%

Mid Cap

7,776 Cr

P/E: 15.2x

Industry P/E: 27.8x

Fundamentals

Sales (Cr)	₹ 4,726
Growth	8.3%
EBITDA	19.1%
P/S	1.6x
Dividend	0.2%
P/E	15.2x
Book Value	₹ 10
PEG Ratio	1.8x
ROE	554.9%
P/B	N/A

Shareholding Pattern

Institutions

Sbi Long Term Equity Fund

6.67 %

Aditya Birla Sun Life Trustee Private Limited

6.5 %

Life Insurance Corporation Of India P & Gs Fund

4.61 %

Route One Offshore Master Fund, L.P.

4.46 %

Route One Fund I, L.P.

2.99 %

Promoters

Pronomz Ventures Llp

18.37 %

Arun Kumar Pillai

1.54 %

K R Ravishankar

1.4 %

Karuna Business Solutions Llp

1.36 %

Shasun Leasing And Finance (P) Limited

1.12 %

Others

Increase Decrease No change

Company Profile Detailed

The company’s core competence is in the development and manufacture of wide range of niche and technically complex pharmaceutical products. The company is also among the world's largest soft gelatin capsule manufacturers.ProductsSoft gel capsules - The company manufactures range of soft gel in category of nutraceuticals, Rx, specialty OTCs and immunosuppressants.Steriles- Under this, it offers its products in therapeutic segments that includes beta-lactams and cephalosporins.

Belongs to (12 Indices) view more

Investors (182)

credit.s...

sbi.mutu...

dsp.blac...

Followers (10)

chetan

damerla

swaroop